The impact of pharmacokinetic gene profiles across human cancers

[11] Borad MJ(2014)The 'dnet' approach promotes emerging research on cancer patient survival Genome Med 6 64-574

[12] Egan JB(2011)CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network Clin Pharmacol Ther 89 464-494

[13] Condjella RM(2013)ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Genet Med 15 565-867

[14] Liang WS(2015)Whole-genome characterization of chemoresistant ovarian cancer Nature 521 489-342

[15] Fonseca R(2006)Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel Mol Cancer Ther 5 853-433

[16] Ritacca NR(2001)Germline mutation of dihydropyrimidine dehydrogenese gene among a Japanese population in relation to toxicity to 5-fluorouracil Jpn J Cancer Res 92 337-895

[17] McCullough AE(2010)Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 417-127

[18] Barrett MT(1991)Mechanisms of bacterial resistance to antibiotics Arch Intern Med 151 886-1792

[19] Hunt KS(1979)Clinical pharmacokinetics Annu Rev Pharmacol Toxicol 19 105-721

[20] Champion MD(2014)Drug resistance in cancer: an overview Cancers (Basel) 6 1769-220

[11] Borad MJ(2014)The 'dnet' approach promotes emerging research on cancer patient survival Genome Med 6 64-574

[12] Egan JB(2011)CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network Clin Pharmacol Ther 89 464-494

[13] Condjella RM(2013)ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Genet Med 15 565-867

[14] Liang WS(2015)Whole-genome characterization of chemoresistant ovarian cancer Nature 521 489-342

[15] Fonseca R(2006)Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel Mol Cancer Ther 5 853-433

[16] Ritacca NR(2001)Germline mutation of dihydropyrimidine dehydrogenese gene among a Japanese population in relation to toxicity to 5-fluorouracil Jpn J Cancer Res 92 337-895

[17] McCullough AE(2010)Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 417-127

[18] Barrett MT(1991)Mechanisms of bacterial resistance to antibiotics Arch Intern Med 151 886-1792

[19] Hunt KS(1979)Clinical pharmacokinetics Annu Rev Pharmacol Toxicol 19 105-721

[20] Champion MD(2014)Drug resistance in cancer: an overview Cancers (Basel) 6 1769-220